Camptothecins New Anticancer Agents
This exciting new book presents the first comprehensive overview of clinical trials of camptothecins, a new class of anticancer agents. Camptothecins are synthetic and semisynthetic derivatives of a plant alkaloid that inhibit a cellular enzyme and trigger a cascade of events leading to programmed cell death. Special attention is given to the adverse effects of camptothecin treatment, as well as to prevention and control.
The book boasts contributions by some of the most respected authorities in camptothecin research, who have
Відгуки відвідувачів - Написати рецензію
Не знайдено жодних рецензій.
Review of Clinical Trials with Camptothecin Sodium
Clinical Trial and Pharmacokinetic Results with Oral Administration
acid acuminata administration agents analogs anticancer antitumor activity assay breaks camptothecin camptothecin derivatives Cancer Chemother Cancer Res cell cell lines Chapter Chem chemotherapy Clin clinical trials colon complex compounds concentration continuous correlation courses cytotoxicity daily determined diarrhea DNA topoisomerase dose dose level dose-limiting drug early effects enzyme evaluation Figure gastrointestinal gene Giovanella Grade half-life human induced infusion inhibition inhibitor initial Institute Introduction irinotecan isolated lactone less leukemia levels lung cancer mammalian mechanism mg/m² mice mouse mutation neutropenia observed Oncol Oncology patients pharmacokinetics Pharmacology Phase I study Phase I trial Plant plasma Potmesil preclinical Proc reaction replication reported Research resistance response ring salt schedule showed shown single sodium Stehlin structure synthesis Table testing therapy thrombocytopenia topo topotecan toxicity treated treatment tumor University vitro vivo Wall Wani water-soluble weekly weeks xenografts
Усі результати пошуку книг »